Table I-33Strength of evidence for divalproex compared with placebo

Domains Pertaining to Strength of EvidenceMagnitude of EffectStrength of Evidence
Number of Studies;
Number of Subjects
Risk of Bias; DesignConsistencyDirectnessPrecisionSummary Effect Size (95% CI)High, Moderate, Low, Insufficient
PTSD Symptom Reduction: CAPS
1; 85Low; RCTNA, single studyDirectImpreciseWMD −1.40, p=nsInsufficient
Prevention/reduction of comorbid depression: MADRS
1; 85Low; RCTNA, single studyDirectImpreciseWMD −0.6, p=nsInsufficient
Prevention/reduction of comorbid anxiety: HAM-A
1; 85Low; RCTNA, single studyDirectImpreciseWMD 1.4, p=nsInsufficient

From: Appendix I, Strength of Evidence

Cover of Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder: A Systematic Review Update
Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder: A Systematic Review Update [Internet].
Comparative Effectiveness Review, No. 207.
Forman-Hoffman V, Middleton JC, Feltner C, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.